SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001600620-23-000041
Filing Date
2023-09-22
Accepted
2023-09-22 16:31:41
Documents
1
Period of Report
2023-09-21

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1695414684.html 3  
1 FORM 3 wk-form3_1695414684.xml 3 1620
  Complete submission text file 0001600620-23-000041.txt   2973
Mailing Address #140, 14315 - 118 AVENUE EDMONTON A0 T5L 4S6
Business Address #140, 14315 - 118 AVENUE EDMONTON A0 T5L 4S6 250-744-2487
Aurinia Pharmaceuticals Inc. (Issuer) CIK: 0001600620 (see all company filings)

IRS No.: 981231763 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CONTRAVIR PHARMACEUTICALS, INC. 399 THORNALL STREET, FIRST FLOOR EDISON NJ 08837
Business Address
Foster Robert T (Reporting) CIK: 0001677370 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36421 | Film No.: 231272125